AGIO
Agios Pharmaceuticals, Inc.
31.80$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 69.9% | 89.0% | 78.1% | 81.8% | 60.0% | 58.1% | 62.3% | 69.3% | 74.6% | 72.6% | 70.5% | 64.7% | |
| 6.4% | 9.4% | 14.0% | 10.9% | 14.2% | 4.6% | 5.1% | 5.5% | 6.7% | 6.9% | 9.6% | 9.0% | |
| 64.3% | 82.9% | 70.4% | 73.7% | 56.1% | 53.7% | 57.4% | 63.8% | 68.8% | 65.9% | 62.2% | 55.7% | |
| 0.1% | 0.3% | 0.4% | 0.5% | 0.2% | 0.2% | 0.2% | 0.3% | 0.4% | 0.8% | 1.4% | 1.8% | |
| 1.7% | 2.0% | 2.7% | 3.1% | 1.5% | 1.7% | 1.9% | 2.1% | 2.3% | 2.5% | 3.0% | 2.7% | |
| 7.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 12.0% | 13.5% | 12.4% | 14.6% | 9.2% | 7.3% | 5.7% | 6.9% | 7.3% | 8.0% | 6.4% | 7.4% | |
| 5.8% | 7.3% | 6.1% | 8.1% | 6.7% | 4.9% | 3.4% | 4.8% | 5.4% | 6.3% | 5.0% | 6.3% | |
| 1.5% | 1.6% | 1.8% | 2.1% | 0.9% | 1.0% | 1.1% | 1.2% | 1.3% | 1.4% | 1.6% | 1.7% | |
| 1.3% | 1.0% | 1.3% | 1.3% | 1.0% | 1.0% | 0.9% | 1.2% | 1.4% | 1.4% | 1.2% | 1.5% | |
| 88.0% | 86.5% | 87.6% | 85.4% | 90.8% | 92.7% | 94.3% | 93.1% | 92.7% | 92.0% | 93.6% | 92.6% | |
| -72.1% | -87.8% | -106.4% | -129.4% | -2.9% | -9.0% | -15.3% | -23.8% | -32.7% | -43.3% | -55.8% | -68.7% | |
| 5.5% | 6.0% | 6.6% | 7.3% | 3.3% | 3.4% | 3.7% | 3.9% | 4.2% | 4.5% | 5.0% | 5.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.